Alnylam Pharmaceuticals

ALNY

Rank 915

Country USA

Exchange NASDAQ

Currency USD

Sector LIFE SCIENCES

Industry PHARMACEUTICAL PREPARATIONS

Address 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US

Alnylam Pharmaceuticals - Key figures

Market cap 15.28 Billion

Revenue 879.98 Million

Profit 704.14 Million

P/E Ratio No information

P/s Ratio 17.36

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies.

The company is headquartered in Cambridge, Massachusetts.